The No1 Bulgarian healthcare company Sopharma Trading expands operations in Serbia2018-06-22

Sopharma Trading, the No 1 Bulgarian company by revenue in healthcare, is ready to expand its operations on the Serbian market and to become a strategic investor in the region. The CEO of Sopharma Trading Group Dimitar Dimitrov and the CEO of the local operations Milos Ristic informed today the media and the pharma business community about company's strategic plan.

As an innovator, operating in key healthcare segments - wholesale, retail, medical equipment etc., Sopharma Trading is planning to implement its successful diversified business model in Serbia and the whole region. Looking for scale and continuous dynamic growth, the company started regional expansion 3 years ago by opening its subsidiary in Belgrade focused on exclusive brands in health & beauty. In 2017 the company finalized the acquisition of majority shares of Lekovit as a first step to national leadership position.

'The first step is to become leader in Serbia by expanding significantly operations and logistics potential. This development will be used as fundament for the regional expansion, since Sopharma Trading sees the whole region of East Europe and in particular Balkans as a vast opportunity for growth', DImitar Dimitrov stated.

The company will bring world best practices, technology and innovations to the region. 'As an innovator and pioneer in its homeland operations, Sopharma Trading is looking to the future - we will bring to the Serbian market and the whole region - modern, world-leading technologies and practices in different sectors such as wholesale, pharmacy retail and medical equipment.', Milos Ristic shared.

Attachments

  • Original document
  • Permalink

Disclaimer

Sopharma Trading AD published this content on 22 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 22 June 2018 10:47:11 UTC